KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Rh (RH) EBITDA (2016 - 2025)

Historic EBITDA for Rh (RH) over the last 15 years, with Q4 2025 value amounting to $105.9 million.

  • Rh's EBITDA rose 439.74% to $105.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was $361.0 million, marking a year-over-year increase of 1406.99%. This contributed to the annual value of $322.6 million for FY2025, which is 1187.86% down from last year.
  • As of Q4 2025, Rh's EBITDA stood at $105.9 million, which was up 439.74% from $128.9 million recorded in Q3 2025.
  • In the past 5 years, Rh's EBITDA ranged from a high of $272.5 million in Q4 2021 and a low of $51.2 million during Q4 2023
  • Its 5-year average for EBITDA is $140.6 million, with a median of $120.5 million in 2023.
  • As far as peak fluctuations go, Rh's EBITDA soared by 42996.36% in 2021, and later crashed by 6990.54% in 2023.
  • Rh's EBITDA (Quarter) stood at $272.5 million in 2021, then crashed by 37.53% to $170.2 million in 2022, then tumbled by 69.91% to $51.2 million in 2023, then surged by 98.04% to $101.5 million in 2024, then rose by 4.4% to $105.9 million in 2025.
  • Its EBITDA stands at $105.9 million for Q4 2025, versus $128.9 million for Q3 2025 and $55.9 million for Q2 2025.